Journal Article FZJ-2019-02119

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
O‑(2‑[18F]‑fluoroethyl)-L‑tyrosine (FET) in neurooncology: A review of experimental results

 ;  ;  ;

2019
Bentham Science Publ. Sharjah

Current radiopharmaceuticals 12(3), 201-210 () [10.2174/1874471012666190111111046]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: In recent years, PET using radiolabelled amino acids has gained considerable interest as an additional tool besides MRI to improve the diagnosis of cerebral gliomas and brain metastases. A very successful tracer in this field is O-(2-[18F]fluoroethyl)-L-tyrosine (FET) which in recent years has replaced short-lived tracers such as [11C]-methyl-L-methionine in many neuro-oncological centers in Western Europe. FET can be produced with high efficiency and distributed in a satellite concept like 2- [18F]fluoro-2-deoxy-D-glucose. Many clinical studies have demonstrated that FET PET provides important diagnostic information regarding the delineation of cerebral gliomas for therapy planning, an improved differentiation of tumor recurrence from treatment-related changes and sensitive treatment monitoring. In parallel, a considerable number of experimental studies have investigated the uptake mechanisms of FET on the cellular level and the behavior of the tracer in various benign lesions in order to clarify the specificity of FET uptake for tumor tissue. Further studies have explored the effects of treatment related tissue alterations on tracer uptake such as surgery, radiation and drug therapy. Finally, the role of blood-brain barrier integrity for FET uptake which presents an important aspect for PET tracers targeting neoplastic lesions in the brain has been investigated in several studies. Based on a literature research regarding experimental FET studies and corresponding clinical applications this article summarizes the knowledge on the uptake behavior of FET, which has been collected in more than 30 experimental studies during the last two decades and discusses the role of these results in the clinical context.

Classification:

Contributing Institute(s):
  1. Physik der Medizinischen Bildgebung (INM-4)
Research Program(s):
  1. 573 - Neuroimaging (POF3-573) (POF3-573)

Appears in the scientific report 2019
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; Emerging Sources Citation Index ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Dokumenttypen > Aufsätze > Zeitschriftenaufsätze
Institutssammlungen > INM > INM-4
Workflowsammlungen > Öffentliche Einträge
Publikationsdatenbank

 Datensatz erzeugt am 2019-03-26, letzte Änderung am 2021-01-30



Dieses Dokument bewerten:

Rate this document:
1
2
3
 
(Bisher nicht rezensiert)